- Home
- PRZO vs GCTK Comparison
PRZO vs GCTK Comparison
Compare PRZO & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- GCTK
- Stock Information
- Founded
- PRZO 2014
- GCTK 2001
- Country
- PRZO Israel
- GCTK United States
- Employees
- PRZO N/A
- GCTK N/A
- Industry
- PRZO
- GCTK Medical/Dental Instruments
- Sector
- PRZO
- GCTK Health Care
- Exchange
- PRZO Nasdaq
- GCTK Nasdaq
- Market Cap
- PRZO 25.7M
- GCTK 3.3M
- IPO Year
- PRZO 2023
- GCTK N/A
- Fundamental
- Price
- PRZO $1.58
- GCTK $7.40
- Analyst Decision
- PRZO
- GCTK
- Analyst Count
- PRZO 0
- GCTK 0
- Target Price
- PRZO N/A
- GCTK N/A
- AVG Volume (30 Days)
- PRZO 811.2K
- GCTK 4.1M
- Earning Date
- PRZO 08-28-2025
- GCTK 11-13-2025
- Dividend Yield
- PRZO N/A
- GCTK N/A
- EPS Growth
- PRZO N/A
- GCTK N/A
- EPS
- PRZO N/A
- GCTK N/A
- Revenue
- PRZO $1,007,440.00
- GCTK N/A
- Revenue This Year
- PRZO N/A
- GCTK N/A
- Revenue Next Year
- PRZO N/A
- GCTK N/A
- P/E Ratio
- PRZO N/A
- GCTK N/A
- Revenue Growth
- PRZO 80.42
- GCTK N/A
- 52 Week Low
- PRZO $0.53
- GCTK $4.22
- 52 Week High
- PRZO $3.16
- GCTK $3,576.00
- Technical
- Relative Strength Index (RSI)
- PRZO 59.61
- GCTK 57.35
- Support Level
- PRZO $1.40
- GCTK $7.20
- Resistance Level
- PRZO $1.58
- GCTK $14.14
- Average True Range (ATR)
- PRZO 0.08
- GCTK 1.02
- MACD
- PRZO 0.03
- GCTK 0.37
- Stochastic Oscillator
- PRZO 99.65
- GCTK 32.24
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.